Hydrochloric Acid

Hydrochloric Acid

SCHEMBL378591

Cl.Cl.Nc1ccc(N)cc1

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.57
MAOA known ✓ P21397 1/20 0.47
MAOB known ✓ P27338 1/20 0.47
MEN1 O00255 2/20 0.89
MAPT P10636 2/20 0.89
KMT2A Q03164 2/20 0.89
CYP3A4 P08684 8/20 0.67
TDP1 Q9NUW8 8/20 0.67
ALDH1A1 P00352 7/20 0.67
TP53 P04637 2/20 0.67
MAPK1 P28482 4/20 0.57
ALOX15 P16050 3/20 0.57
HSD17B10 Q99714 2/20 0.57
CA3 P07451 1/20 0.57
THRB P10828 1/20 0.57
CA6 P23280 1/20 0.57
CASP1 P29466 1/20 0.57
HIF1A Q16665 1/20 0.57
CA14 Q9ULX7 1/20 0.57
TSHR P16473 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL135990 1.00
Hydrochloric Acid SCHEMBL4949584 1.00 MEN1 (0.89) MEN1MAPTKMT2ACYP3A4TDP1
Hydrochloric Acid SCHEMBL3672319 1.00 MEN1 (0.89) MEN1MAPTKMT2ACYP3A4TDP1
Hydrochloric Acid SCHEMBL28945243 0.95 MEN1 (0.80) MEN1MAPTKMT2ACYP3A4TDP1
Hydrochloric Acid SCHEMBL21523285 0.95 MEN1 (0.80) MEN1MAPTKMT2ACYP3A4TDP1
Hydrochloric Acid SCHEMBL10638088 0.95 MEN1 (0.80) MEN1MAPTKMT2ACYP3A4TDP1
Hydrochloric Acid SCHEMBL7371349 0.95 MEN1 (0.80) MEN1MAPTKMT2ACYP3A4TDP1
SCHEMBL27981 0.94
SCHEMBL320609 0.94 MEN1 (1.00) MEN1MAPTKMT2ACYP3A4TDP1
Methylamine SCHEMBL27939730 0.91 MAPT (0.73) MEN1MAPTKMT2ACYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1089 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118524712-A Voltage stabilizing diode and preparation method and application thereof 澳门大学 2024-08-20 CN claimed
EP-4377472-A2 NANOZYME-CATALYSED DETECTION OF NUCLEIC ACIDS Imperial College Innovations Limited (GB) 2024-06-05 EP claimed
WO-2023006704-A2 NANOZYME-CATALYSED DETECTION OF NUCLEIC ACIDS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-02-02 WO claimed
EP-3634365-B1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO KGAA (DE) 2022-08-10 EP claimed
EP-3496818-B1 PROCESS FOR PREPARING HAIR DYE AGENTS HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES HENKEL AG & CO KGAA (DE) 2021-01-20 EP claimed
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles HENKEL AG & CO. KGAA (DE) 2020-08-11 US claimed
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE HENKEL AG & CO. KGAA (DE) 2020-06-04 US claimed
CN-111169127-A Sound-insulation noise-reduction composite corrugated plate tile and production process thereof 界首市丰杨塑业有限公司 2020-05-19 CN claimed
US-20200131431-A1 CHEMICAL ADDITIVES AND SURFACTANT COMBINATIONS FOR FAVORABLE WETTABILITY ALTERATION AND IMPROVED HYDROCARBON RECOVERY FACTORS ALCHEMY SCIENCES INC (US) 2020-04-30 US claimed
EP-3634365-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE Henkel AG & Co. KGaA (DE) 2020-04-15 EP claimed
US-5821320-A MIXING AROMATIC DIAMINE DIHYDROCHLORIDE OR SULFATE WITH AROMATIC ACID DIANHYDRIDE, HEATING TO DEHYDRATE AND CONDENSE PETROLEUM ENERGY CENTER (JP) 1998-10-13 US claimed
US-5707872-A CYANOGEN RELEASING AGENT AND CYANOGEN HALIDE FORMING AGENT FOR TREATMENT OF URINE DYNAGEN, INC. (US) 1998-01-13 US claimed
EP-0634013-B1 System for the detection of nicotine and/or nicotine metabolite DYNAGEN INC (US) 1996-10-30 EP claimed
CN-1105677-A High-regularity ladder polyhydric sesquisiloxane and its copolymer and preparing method thereof CHINESE ACAD INST CHEMISTRY (CN) 1995-07-26 CN claimed
EP-0634013-A1 A NICOTINE AND/OR NICOTINE METABOLITE DETECTION SYSTEM. DYNAGEN INC (US) 1995-01-18 EP claimed
WO-1993020438-A1 A NICOTINE AND/OR NICOTINE METABOLITE DETECTION SYSTEM DYNAGEN, INC. (US) 1993-10-14 WO claimed
CN-1060207-A Two dosage form human hair articles for use and compound methods thereof of dye gigging unification HUADONG CHEMICAL COLLEGE (CN) 1992-04-15 CN claimed
US-5025107-A Process for coproduction of arylene diamine dihalides and alkyl halides EASTMAN KODAK COMPANY (US) 1991-06-18 US claimed
US-4340670-A Method of using over the counter swab kit for self detection of gonorrhea in the male using tetramethyl chromogen ampul MENNEN FREDERICK C 1982-07-20 US claimed
US-4169932-A METHOD OF PRODUCING POLY-P-PHENYLENETEREPHTHALAMIDE OR ITS COPOLYMERS INGERSOLL EQUIPMENT CO., INC., 1979-10-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10736827-B2 Hair dye agent having unilamellar and multilamellar vesicles EXOSC10, ANXA5, ANXA4 ACHE 3441/4885MAOA 1862/4885MAOB 1950/4885
US-20200170904-A1 HAIR COLORING COMPOSITION WITH IMPROVED SALT TOLERANCE UGCG, ADH1C, ELOVL1 ACHE 4725/4885MAOA 793/4885MAOB 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.